DE60319599T8 - Verfahren zur differenzierung einer mesenchym-stammzelle zu einer nervenzelle sowie die nervenzelle enthaltende pharmazeutische zusammensetzung gegen eine neurodegenerative krankheit - Google Patents
Verfahren zur differenzierung einer mesenchym-stammzelle zu einer nervenzelle sowie die nervenzelle enthaltende pharmazeutische zusammensetzung gegen eine neurodegenerative krankheit Download PDFInfo
- Publication number
- DE60319599T8 DE60319599T8 DE60319599T DE60319599T DE60319599T8 DE 60319599 T8 DE60319599 T8 DE 60319599T8 DE 60319599 T DE60319599 T DE 60319599T DE 60319599 T DE60319599 T DE 60319599T DE 60319599 T8 DE60319599 T8 DE 60319599T8
- Authority
- DE
- Germany
- Prior art keywords
- nervenzelle
- stem cell
- differentiating
- pharmaceutical composition
- neurodegenerative disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/12—Hepatocyte growth factor [HGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
- C12N2506/1353—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from bone marrow mesenchymal stem cells (BM-MSC)
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Psychology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/KR2003/002302 WO2005040362A1 (en) | 2003-10-29 | 2003-10-29 | Method for differentiating mesenchymal stem cell into neural cell and pharmaceutical composition containing the neural cell for neurodegenerative disease |
Publications (3)
Publication Number | Publication Date |
---|---|
DE60319599D1 DE60319599D1 (de) | 2008-04-17 |
DE60319599T2 DE60319599T2 (de) | 2008-06-26 |
DE60319599T8 true DE60319599T8 (de) | 2008-10-16 |
Family
ID=34510740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60319599T Active DE60319599T8 (de) | 2003-10-29 | 2003-10-29 | Verfahren zur differenzierung einer mesenchym-stammzelle zu einer nervenzelle sowie die nervenzelle enthaltende pharmazeutische zusammensetzung gegen eine neurodegenerative krankheit |
Country Status (10)
Country | Link |
---|---|
US (1) | US7635591B2 (de) |
EP (1) | EP1687413B8 (de) |
JP (1) | JP4126060B2 (de) |
CN (1) | CN100554409C (de) |
AT (1) | ATE388223T1 (de) |
AU (1) | AU2003273118B2 (de) |
CA (1) | CA2543118C (de) |
DE (1) | DE60319599T8 (de) |
HK (1) | HK1093755A1 (de) |
WO (1) | WO2005040362A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004069172A2 (en) | 2003-01-30 | 2004-08-19 | The Government of the United States of America as represented by the Department of Veterans Affairs | Multilineage-inducible cells and uses thereof |
CN100377165C (zh) * | 2003-04-24 | 2008-03-26 | 皇家飞利浦电子股份有限公司 | 无创式左心室的容积测定 |
US20090136461A1 (en) * | 2007-11-28 | 2009-05-28 | Moon Suk Kim | Neuronal differentiation method of adult stem cells using small molecules |
WO2009085216A2 (en) | 2007-12-20 | 2009-07-09 | Squicor | Compositions and methods for detecting or elimninating senescent cells to diagnose or treat disease |
KR20200011604A (ko) | 2008-08-20 | 2020-02-03 | 안트로제네시스 코포레이션 | 개선된 세포 조성물 및 그의 제조 방법 |
US8790638B2 (en) * | 2009-02-04 | 2014-07-29 | Stemedica Cell Technologies, Inc. | Compositions of stem cells and stem cell factors and methods for their use and manufacture |
CA2756670A1 (en) | 2009-03-26 | 2010-09-30 | The Regents Of The University Of California | Mesenchymal stem cells producing inhibitory rna for disease modification |
CN101948803B (zh) * | 2010-09-13 | 2012-09-05 | 中山大学中山眼科中心 | 人表皮源性间充质干细胞样多能细胞及其制备方法 |
WO2012156968A2 (en) * | 2011-05-19 | 2012-11-22 | Ariel - University Research And Development Company, Ltd. | Use of mesenchymal stem cells for the improvement of affective and cognitive function |
KR101446711B1 (ko) * | 2011-05-23 | 2014-10-06 | 아주대학교산학협력단 | 간세포 성장인자 유전자 및 염기성 나선-고리-나선 계열의 신경형성 전사인자 유전자가 도입된 성체 줄기세포주 및 그의 용도 |
US20140065110A1 (en) | 2012-08-31 | 2014-03-06 | The Regents Of The University Of California | Genetically modified msc and therapeutic methods |
CN103275070A (zh) * | 2013-05-10 | 2013-09-04 | 郑彪 | 调节单核细胞增殖的四环化合物及其应用 |
CN103919806A (zh) * | 2014-04-09 | 2014-07-16 | 大连医科大学 | 骨髓间充质干细胞作为治疗正己烷致周围性神经病的药物的应用 |
CN104004713A (zh) * | 2014-05-14 | 2014-08-27 | 安沂华 | 脐带间充质干细胞诱导培养为神经细胞的方法 |
CN106795490B (zh) * | 2014-09-11 | 2021-01-19 | 台湾粒线体应用技术股份有限公司 | 用线粒体特化细胞治疗神经退行性疾病的医药组合物 |
US20230346847A1 (en) * | 2020-08-24 | 2023-11-02 | The Johns Hopkins University | Juvenile protective factors to arrest and reverse aging in the enteric nervous system |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6214334B1 (en) * | 1991-10-21 | 2001-04-10 | Trustees Of The University Of Pennsylvania | Compositions and methods for producing and using homogenous neuronal cell transplants to treat neurodegenerative disorders and brain and spinal cord injuries |
AU716811B2 (en) | 1994-11-14 | 2000-03-09 | Neurospheres Holdings Ltd | Regulation of neural stem cell proliferation |
US5736396A (en) * | 1995-01-24 | 1998-04-07 | Case Western Reserve University | Lineage-directed induction of human mesenchymal stem cell differentiation |
US7015037B1 (en) * | 1999-08-05 | 2006-03-21 | Regents Of The University Of Minnesota | Multiponent adult stem cells and methods for isolation |
KR100449141B1 (ko) * | 2001-04-19 | 2004-09-21 | (주)라이프코드 | 간엽 간세포를 신경세포로 분화시키는 방법 |
CN1745168A (zh) * | 2002-12-02 | 2006-03-08 | 安增子摩祺株式会社 | 利用肝细胞生长因子培养神经干细胞的方法 |
-
2003
- 2003-10-29 AT AT03754305T patent/ATE388223T1/de active
- 2003-10-29 JP JP2005509875A patent/JP4126060B2/ja not_active Expired - Fee Related
- 2003-10-29 CN CNB2003801106268A patent/CN100554409C/zh not_active Expired - Fee Related
- 2003-10-29 WO PCT/KR2003/002302 patent/WO2005040362A1/en active IP Right Grant
- 2003-10-29 AU AU2003273118A patent/AU2003273118B2/en not_active Ceased
- 2003-10-29 CA CA002543118A patent/CA2543118C/en not_active Expired - Fee Related
- 2003-10-29 EP EP03754305A patent/EP1687413B8/de not_active Expired - Fee Related
- 2003-10-29 US US10/595,620 patent/US7635591B2/en not_active Expired - Fee Related
- 2003-10-29 DE DE60319599T patent/DE60319599T8/de active Active
-
2007
- 2007-01-04 HK HK07100146.6A patent/HK1093755A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2003273118A1 (en) | 2005-05-11 |
ATE388223T1 (de) | 2008-03-15 |
CA2543118A1 (en) | 2005-05-06 |
US7635591B2 (en) | 2009-12-22 |
JP4126060B2 (ja) | 2008-07-30 |
EP1687413A4 (de) | 2006-11-08 |
EP1687413A1 (de) | 2006-08-09 |
DE60319599T2 (de) | 2008-06-26 |
EP1687413B8 (de) | 2008-10-01 |
WO2005040362A1 (en) | 2005-05-06 |
DE60319599D1 (de) | 2008-04-17 |
CA2543118C (en) | 2009-10-06 |
US20070054399A1 (en) | 2007-03-08 |
EP1687413B1 (de) | 2008-03-05 |
AU2003273118B2 (en) | 2007-05-17 |
CN1860224A (zh) | 2006-11-08 |
JP2007528196A (ja) | 2007-10-11 |
HK1093755A1 (en) | 2007-03-09 |
CN100554409C (zh) | 2009-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60319599T8 (de) | Verfahren zur differenzierung einer mesenchym-stammzelle zu einer nervenzelle sowie die nervenzelle enthaltende pharmazeutische zusammensetzung gegen eine neurodegenerative krankheit | |
Russell et al. | Clonal analysis of the proliferation potential of human bone marrow mesenchymal stem cells as a function of potency | |
DE602006018768D1 (de) | Konditionell immortalisierte adulte langzeit-stammzellen und verfahren zur herstellung und verwendung von solchen zellen | |
DK1759536T3 (da) | In vitro-teknikker til anvendelse med stamceller | |
EA200601187A1 (ru) | Стволовые клетки | |
WO2008118392A3 (en) | Synthetic cell platforms and methods of use thereof | |
NZ569543A (en) | Means and methods for influencing the stability of antibody producing cells | |
DK1551954T3 (da) | Cellekultur | |
DE602005021379D1 (de) | System und verfahren zur produktion von antikörpern in der pflanzenzellkultur | |
EP1961823A4 (de) | Fermentations- und kulturverfahren, fermentierter pflanzenextrakt, zusammensetzung mit dem fermentierten pflanzenextrakt, verfahren zur herstellung eines lipopolysaccharids und lipopolysaccharid | |
DE502006002073D1 (de) | Verfahren zur verhinderung der zeitabhängigen rna-expression in biologischen zellen | |
ATE467418T1 (de) | Verfahren und stoffe zur freisetzung eines wachstumsfaktors aus endothelzellen, und nach dem verfahren freigesetzter wachstumsfaktor sowie seine verwendung | |
Wei et al. | Elucidating in vitro cell-cell interaction using a microfluidic coculture system | |
DK1495112T3 (da) | Cellekulturmedium | |
SG11201806843UA (en) | Method for producing activated hepatocyte growth factor (hgf) | |
ATE462013T1 (de) | Verfahren zur kultivierung von zellen zur produktion von substanzen | |
Jang et al. | Advanced in vitro three-dimensional skin models of atopic dermatitis | |
DE602006012425D1 (de) | Verfahren zur herstellung einer voll entwickelten natürlichen killerzelle | |
EP1724755A3 (de) | Verfahren und System zum Vergleich von Tonsignalen und Erkennung einer Tonquelle | |
FR2948381B1 (fr) | Procede d'obtention de myofibroblastes. | |
DE102005007311A1 (de) | Pflanzen mit verminderter Ruheperiode und Verfahren zur Erzeugung der Pflanzen | |
WO2005054447A3 (en) | Müller stem cells | |
Grenier et al. | Optimization of the Self-Assembly Method for the Production of Psoriatic Skin Substitutes | |
FR2924722B1 (fr) | Procede de selection d'agents pour modifier la forme du cheveu et utilisation cosmetique des actifs. | |
ATA144399A (de) | Verfahren zur herstellung eines qualitätsgesicherten pools biologischer proben |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8381 | Inventor (new situation) |
Inventor name: KIM, HYUN-SOO, SUWON-SI, KYUNGGI-DO, KR Inventor name: KANG, YOUNG-MO, SUWON-SI, KYUNGGI-DO, KR Inventor name: LEE, KYUNG-BOCK, SUWON-SI, KYUNGGI-DO, KR Inventor name: PARK, SANG-KYO, PALDAL-GU, SUWON-SI, KYUNGGI-D, KR Inventor name: LEE, SANG-KAP, DAEGU-SI, KR |
|
8364 | No opposition during term of opposition | ||
R082 | Change of representative |
Ref document number: 1687413 Country of ref document: EP Representative=s name: PATENT- UND RECHTSANWAELTE KRAUS & WEISERT, 80539 |